Pilot Study Evaluating CALM Clinical Supervision for Clinicians
Study Objectives:
- We are conducting a pilot study to test the feasibility, efficacy and experience of implementing CALM clinical case supervision, to train oncology healthcare clinicians across Ontario in the delivery of CALM therapy
- The study will assess clinician-level and patient-level outcomes
Format of Supervision:
- Clinical supervision will be delivered via small-group videoconference or in-person meetings
- Meetings will be held weekly or bi-weekly (depending on clinician availability)
- Supervision will be led by Dr. Sarah Hales, psychiatrist and co-creator of CALM therapy
Recruitment and Eligibility:
- We will recruit 20 clinicians from across Ontario, and 40 of their patients, over 2 years
- Clinicians will be: healthcare professionals who have attended a CALM training workshop, are fluent in English, and are employed in a role where they provide direct clinical care to advanced cancer patients
- Their patients will be: ≥ 18 years of age, fluent in English, able to provide informed consent, have a diagnosis of metastatic cancer, and suitable CALM therapy candidates
Clinicial Commitment:
- Participation in weekly or bi-weekly supervision meetings plus delivery of CALM therapy
- Completion of 2 CALM therapy cases competently under supervision (approx. 6-12 months)
For more information, please contact:
Study investigator Dr. Sarah Hales, at: sarah.hales@uhn.ca, or
Study coordinator Joanna Shnall, at: jshnall@uhnresearch.ca
This research study is being funded by the Ontario Ministry of Health and Long Term Care’s AFP Innovation Fund, and has received Research Ethics Approval from Clinical Trials Ontario.
Go back to
Managing Cancer And Living Meaningfully (CALM)
